Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Deutsches Arzteblatt International|September 17, 2024
The Long-Term Cure of Patients With Hereditary Medullary Thyroid Carcinoma: 40 Years of Follow-Up in a Single CenterFriedhelm Raue, Thomas Bruckner, Karin Frank-Raue
The Journal of Clinical Endocrinology and Metabolism|May 11, 2021
Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid CarcinomaFriedhelm Raue, Thomas Bruckner, Karin Frank-Raue
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 19, 2025
Medullary Thyroid Carcinoma: ImagingStefan Delorme, Friedhelm Raue, Bettina Beuthien-Baumann
The Journal of Clinical Endocrinology and Metabolism|May 31, 2019
Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One CenterFriedhelm Raue, Thomas Bruckner, Karin Frank-Raue
Molecular and Cellular Endocrinology|January 20, 2010
Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTCKarin Frank-Raue, Susanne Rondot, Friedhelm Raue
Clinical Laboratory|July 4, 2007
Change in the spectrum of RET mutations diagnosed between 1994 and 2006Karin Frank-Raue, Susanne Rondot, Egbert Schulze, et al.
Surgery|November 4, 2004
Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutationAndreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, et al.
European Journal of Endocrinology|July 28, 2007
Efficacy of imatinib mesylate in advanced medullary thyroid carcinomaKarin Frank-Raue, Michael Fabel, Stefan Delorme, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2017
Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New MillenniumFriedhelm Raue, Henning Dralle, Andreas Machens, et al.
Pageof 8